Opportunities

Significant
Global Market Opportunities

  • “Global OAB market size is expected to hit around USD
    8.2 billion by 2030 from valued at
    USD 3.9 billion in 2022 and growing at a CAGR of 4.6% from 2022 to 2030.”1
  • Total economic impact of OAB estimate at $82B, including 75% in direct spend2,3.
  • Only 5% of candidates for an advanced therapy receive treatment
  • Only 40% of Americans with OAB symptoms seek medical attention due to embarrassment,
    misconception that leaking is part of aging, etc.
  • 80%+ of patients prescribed medications discontinue use within 6 months based on unmet
    treatment expectations, adverse effects, and cost
  • Over 200M people worldwide suffer from OAB
  • Approximately 46 million American adults over the age of 40 have reported symptoms of
    overactive bladder
  • There is a significant needs for device therapy that is affordable, with no
    complication, and used at home
  1. Nova one advisor
  2. Coyne, K. S., et al. (2014). Economic burden of urgency urinary incontinence in the United
    States: a systematic review. Journal of managed care pharmacy : JMCP, 20(2), 130–140.
  3. Ganz, M. L., et al. (2010). Economic costs of overactive bladder in the United States.
    Urology, 75(3), 526-532.